Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Frassoni

Showing results (181-190 of 215) with videos related to

Pageof 22
Sort By:
Bone Marrow Transplantation|July 1, 1996
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)N C Gorin, M Labopin, L Fouillard, et al.
Blood|May 23, 1998
Low transplant mortality in allogeneic bone marrow transplantation for acute myeloid leukemia: a randomized study of low-dose cyclosporin versus low-dose cyclosporin and low-dose methotrexateP Zikos, M T Van Lint, F Frassoni, et al.
Blood|November 5, 1997
Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)A Ferrant, M Labopin, F Frassoni, et al.
British Journal of Haematology|March 23, 1999
Normal primitive haemopoietic progenitors are more frequent than their leukaemic counterpart in newly diagnosed patients with chronic myeloid leukaemia but rapidly decline with timeF Frassoni, M Podestà, G Piaggio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Mobilization/transplantation of Ph1-negative blood progenitor cells in chronic myelogenous leukaemiaA M Carella, M Podestà, E Lerma, et al.
British Journal of Haematology|August 6, 2000
Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of ageA M Raiola, M T Van Lint, T Lamparelli, et al.
Bone Marrow Transplantation|September 1, 2009
Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor typeA Bacigalupo, M Soraru, A Dominietto, et al.
British Journal of Haematology|September 6, 2000
No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)J Y Cahn, M Labopin, J Sierra, et al.
Bone Marrow Transplantation|June 26, 2007
Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplantD Vicente, T Lamparelli, F Gualandi, et al.
Bone Marrow Transplantation|June 6, 2006
Progenitor cells trapped in marrow filters can reduce GvHD and transplant mortalityD Vicente, M Podestà, A Pitto, et al.
Pageof 22

Showing results (181-190 of 215) with videos related to

Sort By:
Pageof 22
Bone Marrow Transplantation|July 1, 1996
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)N C Gorin, M Labopin, L Fouillard, et al.
Blood|May 23, 1998
Low transplant mortality in allogeneic bone marrow transplantation for acute myeloid leukemia: a randomized study of low-dose cyclosporin versus low-dose cyclosporin and low-dose methotrexateP Zikos, M T Van Lint, F Frassoni, et al.
Blood|November 5, 1997
Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)A Ferrant, M Labopin, F Frassoni, et al.
British Journal of Haematology|March 23, 1999
Normal primitive haemopoietic progenitors are more frequent than their leukaemic counterpart in newly diagnosed patients with chronic myeloid leukaemia but rapidly decline with timeF Frassoni, M Podestà, G Piaggio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Mobilization/transplantation of Ph1-negative blood progenitor cells in chronic myelogenous leukaemiaA M Carella, M Podestà, E Lerma, et al.
British Journal of Haematology|August 6, 2000
Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of ageA M Raiola, M T Van Lint, T Lamparelli, et al.
Bone Marrow Transplantation|September 1, 2009
Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor typeA Bacigalupo, M Soraru, A Dominietto, et al.
British Journal of Haematology|September 6, 2000
No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)J Y Cahn, M Labopin, J Sierra, et al.
Bone Marrow Transplantation|June 26, 2007
Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplantD Vicente, T Lamparelli, F Gualandi, et al.
Bone Marrow Transplantation|June 6, 2006
Progenitor cells trapped in marrow filters can reduce GvHD and transplant mortalityD Vicente, M Podestà, A Pitto, et al.
Pageof 22